应用
选项
-
Recombinant Human Nogo Receptor Protein种属: 人(Human) Accession #: Q9BZR6表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to bind rrMAG/Fc Chimera in a functional ELISA.
-
Recombinant Human IL-6/IL-6R alpha Protein种属: 人(Human) Accession #: P08887,P05231表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit M1 mouse myeloid leukemia cell proliferation. The ED50 for this effect is 2.5-12.5 ng/mL.
-
Recombinant Mouse Fas/TNFRSF6/CD95 Protein种属: 小鼠(Mouse) Accession #: P25446表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit Fas Ligand-induced apoptosis of Jurkat human acute T cell leukemia cells. The ED50 for this effect is 0.03‑0.1 µg/mL in the presence of 20 ng/mL recombinant human Fas-ligand.
-
Recombinant Human EphA3 Protein种属: 人(Human) Accession #: P29320表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: 1、Measured by its binding ability in a functional ELISA. When Recombinant Human (rh) EphA3 is coated at 2 μg/mL (100 μL/well), the concentration of biotinylayed rhEphrin A5 Fc Chimera that produces 50% of the optimal binding response is found to be approximately 5 ‑ 25 ng/mL. 2、Immobilized Recombinant Human EphA3 Protein (rp145609) at 1.0 μg/mL can bind Ifabotuzumab (anti-EphA3) (Ab191893) with the EC50 is 13.82 ng/mL.
-
Recombinant Human Cathepsin H Protein种属: 人(Human) Accession #: P09668表达系统: HEK293 蛋白标签: C-10His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to cleave the fluorogenic peptide substrate, Arg-7-amido-4-methylcoumarin (R-AMC). The specific activity is >750 pmol/min/μg, as measured under the described conditions.
-
Recombinant Mouse Activin RIIA Protein种属: 小鼠(Mouse) Accession #: P27038表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit Activin A-induced hemoglobin expression in K562 human chronic myelogenous leukemia cells. The ED50 for this effect is 6-36 ng/mL in the presence of 3 ng/mL of recombinant human Activin A.
-
Recombinant Human CEACAM-5/CD66e Protein种属: 人(Human) Accession #: P06731-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <1.0 EU/μg生物活性: Immobilized Recombinant Human CEACAM-5/CD66e Protein (rp181299) at 1.0 μg/mL can bind Cergutuzumab (anti-CEACAM5) (Ab182774) with the EC50 of 9.86 ng/mL.
-
Recombinant Mouse LAIR1 Protein种属: 小鼠(Mouse) Accession #: Q8BG84-1表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of HT‑29 human colon adenocarcinoma cells. When 5 x 10^4 cells/well are added to Recombinant Mouse LAIR1-coated plates (50 µg/mL with 100 µL/well), approximately 30‑60% will adhere after 10 minutes at 37 ℃.
-
Recombinant Human EphA5 Protein种属: 人(Human) Accession #: B7ZKW7表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. Immobilized Recombinant Human EphA5 at 2 µg/mL (100 µL/well) can bind recombinant mouse Ephrin-A2 Fc Chimera with a linear range of 0.16-10 ng/mL.
-
Recombinant Mouse IL-23R Protein种属: 小鼠(Mouse) Accession #: Q8K4B4表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by its binding ability in a functional ELISA. When Recombinant Mouse IL-23 R is immobilized at 5 µg/mL (100 µL/well) the concentration of Recombinant Mouse IL‑23 that produces 50% of optimal binding response is approximately 5-25 ng/mL.
-
Recombinant Human Activin RIIB Protein种属: 人(Human) Accession #: Q13705表达系统: HEK293 蛋白标签: C-hFc & His 内毒素水平: <0.1 EU/μg生物活性: Measured by its ability to inhibit Activin A-induced hemoglobin expression in K562 human chronic myelogenous leukemia cells. Approximately 0.3-1 µg/mL of rhActivin RIIB/Fc Chimera will inhibit 50% of the biological response due to 3 ng/mL of rhActivin A.
-
Recombinant Mouse CD4 Protein种属: 小鼠(Mouse) Accession #: P06332表达系统: HEK293 蛋白标签: C-His 内毒素水平: <0.1 EU/μg生物活性: Measured by the ability of the immobilized protein to support the adhesion of NIH‑3T3 mouse embryonic fibroblast cells. The ED50 for this effect is 2-12 μg/mL.
首页
400-620-6333











